JNJ-55308942

CAS : 2166558-11-6

Ref. 3D-RLD55811

Informations sur le produit

• Nom: JNJ-55308942

Description

JNJ-55308942 is a human Chinese nalbuphine analog that has been found to have anticancer properties. It works by inhibiting kinases, which are enzymes that play a crucial role in cancer cell growth and survival. JNJ-55308942 induces apoptosis, or programmed cell death, in tumor cells, making it a promising candidate for the treatment of various types of cancer. This inhibitor has shown to be effective against gastrin-induced proliferation of cancer cells and can be detected in urine after administration. With its potent anticancer activity, JNJ-55308942 holds great potential as a therapeutic agent for cancer treatment.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 425.3 g/mol
• Formule: C₁₇H₁₂F₅N₇O
• Degré de pureté: Min. 95%